55 related articles for article (PubMed ID: 26626390)
21. Enzyme inhibition by iminosugars: analysis and insight into the glycosidase-iminosugar dependency of pH.
López Ó; Qing FL; Pedersen CM; Bols M
Bioorg Med Chem; 2013 Aug; 21(16):4755-61. PubMed ID: 23583693
[TBL] [Abstract][Full Text] [Related]
22. Conserved water molecules in family 1 glycosidases: a DXMS and molecular dynamics study.
Teze D; Hendrickx J; Dion M; Tellier C; Woods VL; Tran V; Sanejouand YH
Biochemistry; 2013 Aug; 52(34):5900-10. PubMed ID: 23895259
[TBL] [Abstract][Full Text] [Related]
23. [The interaction between genistein and beta-glucosidase].
Zhang YD; Gao QQ; Yu CH
Yao Xue Xue Bao; 2011 Jun; 46(6):677-82. PubMed ID: 21882528
[TBL] [Abstract][Full Text] [Related]
24. A combined quantum/classical molecular dynamics study of the catalytic mechanism of HIV protease.
Liu H; Müller-Plathe F; van Gunsteren WF
J Mol Biol; 1996 Aug; 261(3):454-69. PubMed ID: 8780786
[TBL] [Abstract][Full Text] [Related]
25. Hydroxynaphthaldehyde phosphate derivatives as potent covalent Schiff base inhibitors of fructose-1,6-bisphosphate aldolase.
Dax C; Coinçon M; Sygusch J; Blonski C
Biochemistry; 2005 Apr; 44(14):5430-43. PubMed ID: 15807536
[TBL] [Abstract][Full Text] [Related]
26. Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexes.
Pranav Kumar SK; Kulkarni VM
Drug Des Discov; 2001; 17(4):293-313. PubMed ID: 11765133
[TBL] [Abstract][Full Text] [Related]
27. Hydrogen bonding and catalysis: a novel explanation for how a single amino acid substitution can change the pH optimum of a glycosidase.
Joshi MD; Sidhu G; Pot I; Brayer GD; Withers SG; McIntosh LP
J Mol Biol; 2000 May; 299(1):255-79. PubMed ID: 10860737
[TBL] [Abstract][Full Text] [Related]
28. Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations.
Lee VS; Nimmanpipug P; Aruksakunwong O; Promsri S; Sompornpisut P; Hannongbua S
J Mol Graph Model; 2007 Sep; 26(2):558-70. PubMed ID: 17468026
[TBL] [Abstract][Full Text] [Related]
29. Solid state NMR studies of hydrogen bonding in a citrate synthase inhibitor complex.
Gu Z; Drueckhammer DG; Kurz L; Liu K; Martin DP; McDermott A
Biochemistry; 1999 Jun; 38(25):8022-31. PubMed ID: 10387046
[TBL] [Abstract][Full Text] [Related]
30. Nanosecond molecular dynamics simulations of Cdc25B and its complex with a 1,4-naphthoquinone inhibitor: implications for rational inhibitor design.
Ko S; Lee W; Lee S; Park H
J Mol Graph Model; 2008 Aug; 27(1):13-9. PubMed ID: 18359256
[TBL] [Abstract][Full Text] [Related]
31. Activation mechanism of claudin-4 by ephrin type-A receptor 2: a molecular dynamics approach.
Bhavaniprasad V; Prabhu Dass JF; Jayanthi S
Mol Biosyst; 2013 Nov; 9(11):2627-34. PubMed ID: 24056764
[TBL] [Abstract][Full Text] [Related]
32. Beta-glycosidase activity toward different glycosidic forms of isoflavones.
Ismail B; Hayes K
J Agric Food Chem; 2005 Jun; 53(12):4918-24. PubMed ID: 15941336
[TBL] [Abstract][Full Text] [Related]
33. Convergent approach toward the synthesis of the stereoisomers of C-6 homologues of 1-deoxynojirimycin and their analogues: evaluation as specific glycosidase inhibitors.
Pandey G; Dumbre SG; Khan MI; Shabab M
J Org Chem; 2006 Oct; 71(22):8481-8. PubMed ID: 17064023
[TBL] [Abstract][Full Text] [Related]
34. Screening α-glucosidase inhibitors from mulberry extracts via DOSY and relaxation-edited NNR.
Shang Q; Xiang JF; Tang YL
Talanta; 2012 Aug; 97():362-7. PubMed ID: 22841093
[TBL] [Abstract][Full Text] [Related]
35. Development of adamantan-1-yl-methoxy-functionalized 1-deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man.
Wennekes T; van den Berg RJ; Donker W; van der Marel GA; Strijland A; Aerts JM; Overkleeft HS
J Org Chem; 2007 Feb; 72(4):1088-97. PubMed ID: 17243712
[TBL] [Abstract][Full Text] [Related]
36. Identification of the active site nucleophile in the thermostable beta-glycosidase from the archaeon Sulfolobus solfataricus expressed in Escherichia coli.
Febbraio F; Barone R; D'Auria S; Rossi M; Nucci R; Piccialli G; De Napoli L; Orrù S; Pucci P
Biochemistry; 1997 Mar; 36(11):3068-75. PubMed ID: 9115982
[TBL] [Abstract][Full Text] [Related]
37. The N-benzyl derivative of the glucosidase inhibitor 1-deoxynojirimycin shows a prolonged half-life and a more complete oral absorption in the rat compared with the N-methyl analog.
Faber ED; van den Broek LA; Oosterhuis EE; Stok BP; Meijer DK
Drug Deliv; 1998; 5(1):3-12. PubMed ID: 19570011
[TBL] [Abstract][Full Text] [Related]
38. High-resolution structures of Neotermes koshunensis β-glucosidase mutants provide insights into the catalytic mechanism and the synthesis of glucoconjugates.
Jeng WY; Wang NC; Lin CT; Chang WJ; Liu CI; Wang AH
Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):829-38. PubMed ID: 22751668
[TBL] [Abstract][Full Text] [Related]
39. QM/MM studies on the glycosylation mechanism of rice BGlu1 β-glucosidase.
Wang J; Hou Q; Dong L; Liu Y; Liu C
J Mol Graph Model; 2011 Sep; 30():148-52. PubMed ID: 21802967
[TBL] [Abstract][Full Text] [Related]
40. Active site dynamics and combined quantum mechanics/molecular mechanics (QM/MM) modelling of a HIV-1 reverse transcriptase/DNA/dTTP complex.
Rungrotmongkol T; Mulholland AJ; Hannongbua S
J Mol Graph Model; 2007 Jul; 26(1):1-13. PubMed ID: 17046299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
